The Delaware Senate sent a clear message on March 12th With a unanimous 21-0 vote, lawmakers approved Senate Bill 226—known as Ryan’s Law—a bill that would require licensed healthcare facilities to allow terminally ill patients with valid medical marijuana cards to use cannabis on their premises. The vote wasn’t close. It wasn’t contested. Every senator present voted yes.
Now the bill moves to the House of Representatives, where it will need similar support before it can be signed into law. For terminally ill patients across Delaware who rely on medical cannabis for comfort and pain management, the stakes couldn’t be more personal.
What Is Ryan’s Law, and Where Did It Come From?
Delaware’s SB 226 models itself directly on a 2021 California measure known as Ryan’s Law, or the Compassionate Access to Medical Cannabis Act. The experience of Jim Bartell, whose son died from cancer, partly inspired the California law. Initially, the hospital denied his son the ability to use medical cannabis during treatment—a situation that highlighted the disconnect between state medical marijuana programs and actual patient care.
The Delaware version, introduced earlier this year on January 15th, by Sen. Marie Pinkney (D) and co-sponsored by a broad coalition of lawmakers from both chambers, carries the same spirit. This act amends Title 16 of the Delaware Code relating to medical marijuana. It aims to ensure that terminally ill patients with a valid state medical marijuana card can continue to access their medicine while hospitalized.
What SB 226 Would Actually Require
The bill would require licensed healthcare facilities, specifically acute care hospitals, following a clarifying amendment, to permit terminally ill cardholders to use medical cannabis on their premises. That doesn’t mean anything goes. The bill establishes a clear, structured framework that balances patient rights with institutional responsibilities.
Patients or their designated caregivers would be responsible for acquiring, administering, and securely storing medical marijuana. Patients must keep it in a locked container in their room or another designated area at all times. The bill explicitly prohibits smoking and vaping, so patients would need to use alternative methods such as tinctures, edibles, or capsules.
Under the new bill, healthcare facilities must verify a patient’s registry ID card and document their cannabis use in medical records. Facilities also need to develop and publish written policies and procedures that govern how they handle medical marijuana. The bill also requires that patients and caregivers notify attending physicians of their use.
The law also shields healthcare professionals and staff from civil or criminal liability when they comply in good faith, except in cases of gross negligence, recklessness, or intentional misconduct.
This careful balancing act was the result of real collaboration. As Sen. Pinkney noted on the Senate floor ahead of the vote, hospitals were actively involved in shaping the legislation: “The hospitals worked very well with me in the process of formalizing this legislation, and so we have created a process where the patients are ultimately responsible for the administration and storage of their medical cannabis.”
A Vote That Reflects Support
The 21-0 Senate vote is meaningful beyond just the numbers. Before reaching the full chamber, SB 226 cleared the Senate Health & Social Services Committee on March 11th, with four favorable votes and three on its merits—a committee result that reflected some nuance, but the floor vote that followed left no ambiguity. No senator voted against the bill. None abstained.
That kind of consensus in a legislative body is rare, especially on cannabis policy. It reflects not just the compassionate intent of the legislation, but also the work done by Sen. Pinkney and her colleagues to address the legitimate concerns of healthcare providers and federal compliance officers before the bill ever came to a vote.
n amendment introduced by the bill’s sponsor and adopted in committee specifically clarified that the law would apply to licensed acute care hospitals rather than a broader range of healthcare facilities—a refinement that brought the medical community more firmly on board.
The Delaware Healthcare Association publicly expressed support for the bill, and input from the Medical Society of Delaware also helped shape the final language. When a cannabis bill draws support from hospitals, physicians, and legislators in equal measure, it signals something more than political maneuvering. It signals that the policy makes sense on the ground.
Why This Matters for Terminally Ill Patients
For patients in the final stages of a terminal illness, access to effective symptom management is not a luxury. It is part of basic dignity. Many patients and clinicians recognize medical cannabis as a useful tool for managing pain, nausea, anxiety, and appetite loss: conditions especially prevalent in terminal diagnoses.
Delaware has had an active medical marijuana program for years, and the state’s adult-use cannabis market officially launched in August 2025. However, before the passage of SB 226, hospitals could deny a terminally ill patient access to their medicine, even if they held a valid medical marijuana card.
That gap in the law has meant that some of the most vulnerable patients in the healthcare system—those with no expectation of recovery—have been placed in an impossible position. They must either forgo a treatment that provides them relief, or use it covertly and without the knowledge of their care team. Neither outcome serves the patient.
Ryan’s Law changes that equation. By bringing medical cannabis use into the formal medical record and establishing clear protocols for its use in acute care settings, the bill doesn’t just expand access—it integrates cannabis into the broader care framework in a responsible, transparent way.
A Humane Step Forward for Delaware
With the Senate unanimously behind it, SB 226 now moves to the Delaware House of Representatives. If passed there and signed into law, the act would take effect one year after enactment—giving healthcare facilities time to develop the required policies and procedures before compliance becomes mandatory.
The passage of SB 226 through the Delaware Senate is a significant moment for medical cannabis policy in the state. The unanimous vote speaks to how thoroughly the bill was developed and how widely its goals are understood.
Terminal illness is not a policy abstraction—it is a reality that touches families every day. The ability to access a legally permitted medical treatment during some of the most difficult moments of a person’s life should not hinge on whether they happen to be at home or in a hospital bed.
Ryan’s Law is a straightforward and compassionate correction to a gap in the law. The House now has the opportunity to finish the job.
